The lyophilized powder is a white, hygroscopic solid that should be protected from light and moisture
Unveiling the Good, Bad, and Alternative
If well tolerated after 2 weeks with stable liver enzymes, consider titration to 250-300 mcg daily
During this meeting, the advisory committee will: Review available safety and efficacy data for BPC-157, including preclinical studies and any available clinical evidence Consider public comments submitted by patients, practitioners, and industry stakeholders Evaluate the clinical need for compounded BPC-157 and the patient populations that would benefit Assess the compounding quality considerations specific to peptide formulations Issue a recommendation to the FDA on whether BPC-157 should be included on the 503A compounding list Possible outcomes include: Positive recommendation: PCAC advises the FDA to add BPC-157 to the 503A list, clearing the way for legal compounding nationwide
Injection-site reactions (redness, swelling) occur in 58% of users
Increased uptake of non-pathogenic E